Loading...
XASX
VLS
Market cap94mUSD
Jul 10, Last price  
2.50AUD
1D
1.21%
1Q
-3.47%
Jan 2017
92.31%
IPO
1,462.50%
Name

Vita Life Sciences Ltd

Chart & Performance

D1W1MN
XASX:VLS chart
P/E
13.03
P/S
1.46
EPS
0.19
Div Yield, %
4.40%
Shrs. gr., 5y
1.57%
Rev. gr., 5y
14.95%
Revenues
93m
+17.31%
11,869,88414,376,27017,015,12820,190,56124,266,64630,191,00035,411,00036,580,00038,584,00037,858,00037,738,00041,151,00042,452,00046,481,00057,101,00066,886,00074,161,00079,505,00093,270,000
Net income
10m
+18.80%
-253,385353,477-328,1934,459,5191,212,5212,367,0004,748,0007,280,0004,391,0003,343,0002,863,0002,439,0003,136,0006,094,0008,292,0007,084,0009,080,0008,784,00010,435,000
CFO
16m
+166.87%
0567,416-2,390,377-838,6525,661,5801,383,0004,835,0006,115,0004,923,0004,710,0003,218,0002,842,0002,028,0007,544,0005,889,0002,775,00012,982,0006,155,00016,425,999
Dividend
Sep 19, 20250.045 AUD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Vita Life Sciences Limited is an Australian healthcare company specializing in the formulation, packaging, distribution, and sale of vitamins and nutritional supplements. The company's reach spans Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. In addition to core supplements, their product range encompasses minerals, various herbs, and superfoods. They offer solutions targeting a broad spectrum of therapeutic areas, including nervous system support, general nutrition, immunity, hair, skin, and nails, liver and digestion, weight management, cardiovascular health, pain and inflammation, pregnancy and breastfeeding, and health specifically for men, women, and children. Products also provide antioxidant benefits and support for bones and joints. Marketed under their prominent brands—Herbs of Gold, VitaHealth, and VitaScience—these offerings are sold through pharmacies and health food channels. Established in 1947, Vita Life Sciences Limited is headquartered in Kirrawee, Australia.
IPO date
Aug 23, 2007
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT